Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 1069
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
LV Penstrep-400 - V/NRP/12/0043 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01RA01 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Procaine benzylpenicillin,Dihydrostreptomycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/12/0043-01 1 Stikla flakons ar bromobutila aizbāzni, 50 ml -
V/NRP/12/0043-03 1 Stikla flakons ar bromobutila aizbāzni, 100 ml -
Vanguard Plus 7 - V/NRP/03/1610 Zoetis Belgium S.A., Beļģija QI07AI02 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Live attenuated Canine Distemper virus, strain Snyder Hill, Live attenuated Canine Adenovirus type 2 (CAV2), strain Manhattan, Live attenuated Canine Parainfluenza virus, strain NL-CPI-5, Live attenuated Canine Parvovirus, strain NL-35-D, Inactivated Leptospira canicola, strain C-51, Inactivated Leptospira icterohaemorrhagiae, strain NADL (11403)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 08-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 2212122_LI (22-Dec-2022)
Labelling text: [DOCX] 221222_M (22-Dec-2022)
Summary of product characteristics: [DOCX] 221222_ZA (22-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1610-01 1 deva 25 Flakons, 1 deva -
V/NRP/03/1610-02 1 deva 1 Flakons, 1 deva -
V/NRP/03/1610-03 1 deva 10 Flakons, 1 deva -
V/NRP/03/1610-04 1 deva 100 Flakons, 1 deva -
TAbic M.B. - V/NRP/10/0031 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: Effervescent tablet
International name (active substance): Attenuated Infectious Bursal disease virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 27-Oct-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/10/0031-02 10 Alumīnija blisteris, 100 deva -
V/NRP/10/0031-04 10 Alumīnija blisteris, 500 deva -
V/NRP/10/0031-06 10 Alumīnija blisteris, 1000 deva -
V/NRP/10/0031-08 10 Alumīnija blisteris, 2000 deva -
V/NRP/10/0031-10 10 Alumīnija blisteris, 2500 deva -
V/NRP/10/0031-12 10 Alumīnija blisteris, 5000 deva -
V/NRP/10/0031-14 10 Alumīnija blisteris, 10000 deva -
BOVIGEN SCOUR - V/MRP/15/0039 FORTE Healthcare Limited, Īrija QI02AL01 cattle Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated bovine rotavirus strain TM-91, serotype G6P1, Inactivated bovine coronavirus strain C-197, Inactivated Escherichia coli strain EC/17 expressing F5 (K99) Adhesin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release PHARMAGAL BIO s.r.o., Slovākija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0039-01 1 Stikla flakons, 5 deva -
V/MRP/15/0039-02 1 Stikla flakons, 30 deva -
V/MRP/15/0039-03 1 Stikla pudele, 150 deva -
V/MRP/15/0039-04 1 Plastmasas pudele, 150 deva -
Marbocyl 10% 100 mg/ml V/NRP/08/1578 Vetoquinol S.A., Francija QJ01MA93 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1578-01 100 mg/ml 1 Stikla flakons, 20 ml -
V/NRP/08/1578-02 100 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/08/1578-03 100 mg/ml 1 Stikla flakons, 100 ml -
V/NRP/08/1578-04 100 mg/ml 1 Stikla flakons, 250 ml -
Marbocyl 2% 20 mg/ml V/NRP/03/1545 Vetoquinol S.A., Francija QJ01MA93 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1545-01 20 mg/ml 1 Flakons, 20 ml -
V/NRP/03/1545-02 20 mg/ml 1 Flakons, 50 ml -
V/NRP/03/1545-03 20 mg/ml 1 Flakons, 100 ml -
V/NRP/03/1545-04 20 mg/ml 1 Flakons, 250 ml -
Milbetab 2.5/25 mg - V/DCP/25/0060 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QP54AB51 small dogs; puppies Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Limited, Īrija
Date of authorisation/renewal: 01-Sep-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0060-01 1 Blisteris, 2 tablete -
V/DCP/25/0060-02 2 Blisteris, 2 tablete -
V/DCP/25/0060-03 1 Blisteris, 4 tablete -
V/DCP/25/0060-04 4 Blisteris, 2 tablete -
V/DCP/25/0060-05 2 Blisteris, 4 tablete -
V/DCP/25/0060-06 5 Blisteris, 2 tablete -
V/DCP/25/0060-07 1 Blisteris, 10 tablete -
V/DCP/25/0060-08 4 Blisteris, 4 tablete -
V/DCP/25/0060-09 2 Blisteris, 8 tablete -
V/DCP/25/0060-10 10 Blisteris, 2 tablete -
V/DCP/25/0060-11 5 Blisteris, 4 tablete -
V/DCP/25/0060-12 2 Blisteris, 10 tablete -
V/DCP/25/0060-13 6 Blisteris, 4 tablete -
V/DCP/25/0060-14 3 Blisteris, 8 tablete -
V/DCP/25/0060-15 3 Blisteris, 10 tablete -
V/DCP/25/0060-16 15 Blisteris, 2 tablete -
V/DCP/25/0060-17 8 Blisteris, 4 tablete -
V/DCP/25/0060-18 4 Blisteris, 8 tablete -
V/DCP/25/0060-19 10 Blisteris, 4 tablete -
V/DCP/25/0060-20 5 Blisteris, 8 tablete -
V/DCP/25/0060-21 4 Blisteris, 10 tablete -
V/DCP/25/0060-22 24 Blisteris, 2 tablete -
V/DCP/25/0060-23 12 Blisteris, 4 tablete -
V/DCP/25/0060-24 6 Blisteris, 8 tablete -
V/DCP/25/0060-25 5 Blisteris, 10 tablete -
V/DCP/25/0060-26 12 Blisteris, 8 tablete -
V/DCP/25/0060-27 10 Blisteris, 10 tablete -
Tolzesya 50 mg/ml V/DCP/10/0021 KRKA, d.d., Novo mesto, Slovēnija QP51AJ01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Toltrazuril
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 29-May-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0021-01 50 mg/ml 1 Pudelīte, 250 ml -
V/DCP/10/0021-02 50 mg/ml 1 Plastmasas pudele, 1000 ml -
Nobilis Rismavac + CA126 - V/NRP/02/1467 Intervet International B.V., Nīderlande QI01AD03 chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Turkey herpesvirus, strain FC-126 (cell-associated), live, Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 12-Nov-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1467-01 1 Stikla ampula, 1000 deva -
V/NRP/02/1467-02 1 Stikla ampula, 2000 deva -
V/NRP/02/1467-03 1 Stikla ampula, 4000 deva -
V/NRP/02/1467-04 1 Stikla ampula, 5000 deva -
Masterflox 40 mg/ml V/DCP/14/0020 Fatro S.p.A., Itālija QJ01MA93 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 01-Apr-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0020-01 40 mg/ml 1 Stikla pudele (dzintarkrāsas), 50 ml -
V/DCP/14/0020-02 40 mg/ml 1 Stikla pudele (dzintarkrāsas), 100 ml -
V/DCP/14/0020-03 40 mg/ml 6 Stikla pudele (dzintarkrāsas), 100 ml -
V/DCP/14/0020-04 40 mg/ml 1 Stikla pudele (dzintarkrāsas), 250 ml -
HatchPak Avinew - V/MRP/08/1607 Boehringer Ingelheim Animal Health France SCS , Francija QI01AD06 chickens Vairāk

Medicinal product information

Pharmaceutical form: frozen suspension for oculonasal use
International name (active substance): Live Newcastle Disease virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Animal Health France SCS, Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1607-01 1 Stikla ampula, 10000 deva -
V/MRP/08/1607-02 1 Stikla ampula, 15000 deva -
Solupam 5 mg/ml V/DCP/18/0077 Dechra Regulatory B.V., Nīderlande QN05BA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Diazepam
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0077-01 1 Stikla flakons, 5 ml -
V/DCP/18/0077-02 1 Stikla flakons, 10 ml -
V/DCP/18/0077-03 1 Stikla flakons, 20 ml -
V/DCP/18/0077-04 1 Stikla flakons, 50 ml -
V/DCP/18/0077-05 6 Stikla flakons, 5 ml -
V/DCP/18/0077-06 6 Stikla flakons, 10 ml -
V/DCP/18/0077-07 6 Stikla flakons, 20 ml -
V/DCP/18/0077-08 10 Stikla flakons, 5 ml -
V/DCP/18/0077-09 10 Stikla flakons, 10 ml -
V/DCP/18/0077-10 10 Stikla flakons, 20 ml -
Ataxxa 200 mg/40 mg - V/DCP/15/0035 KRKA, d.d., Novo mesto, Slovēnija QP53AC54 dogs up to 4 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (22-Jun-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0035-01 1 Polipropilēna pipete, 1 deva [PDF] [PDF] [PDF] [PDF]
V/DCP/15/0035-02 4 Polipropilēna pipete, 1 deva [PDF] [PDF]
V/DCP/15/0035-03 6 Polipropilēna pipete, 1 deva -
V/DCP/15/0035-04 10 Polipropilēna pipete, 1 deva -
V/DCP/15/0035-05 3 Polipropilēna pipete, 1 deva -
Ataxxa 500 mg/100 mg - V/DCP/15/0036 KRKA, d.d., Novo mesto, Slovēnija QP53AC54 dogs over 4 kg up to 10 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (22-Jun-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0036-01 1 Polipropilēna pipete, 1 deva [PDF] [PDF] [PDF]
V/DCP/15/0036-02 4 Polipropilēna pipete, 1 deva [PDF]
V/DCP/15/0036-03 6 Polipropilēna pipete, 1 deva -
V/DCP/15/0036-04 10 Polipropilēna pipete, 1 deva -
V/DCP/15/0036-05 3 Polipropilēna pipete, 1 deva -
Ataxxa 1250 mg/250 mg - V/DCP/15/0037 KRKA, d.d., Novo mesto, Slovēnija QP53AC54 dogs over 10 kg up to 25 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (22-Jun-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0037-01 1 Polipropilēna pipete, 1 deva [PDF] [PDF] [PDF]
V/DCP/15/0037-02 4 Polipropilēna pipete, 1 deva [PDF]
V/DCP/15/0037-03 6 Polipropilēna pipete, 1 deva -
V/DCP/15/0037-04 10 Polipropilēna pipete, 1 deva -
V/DCP/15/0037-05 3 Polipropilēna pipete, 1 deva -
Ataxxa 2000 mg/400 mg - V/DCP/15/0038 KRKA, d.d., Novo mesto, Slovēnija QP53AC54 dogs over 25 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (22-Jun-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0038-01 1 Polipropilēna pipete, 1 deva [PDF] [PDF] [PDF]
V/DCP/15/0038-02 4 Polipropilēna pipete, 1 deva [PDF] [PDF]
V/DCP/15/0038-03 6 Polipropilēna pipete, 1 deva -
V/DCP/15/0038-04 10 Polipropilēna pipete, 1 deva -
V/DCP/15/0038-05 3 Polipropilēna pipete, 1 deva -
Tsefalen 50 mg/ml V/DCP/20/0050 NEXTMUNE ITALY S.R.L., Itālija QJ01DB01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: Powder for oral suspension
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Facta Farmaceutici Spa , Itālija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0050-01 50 mg/ml 1 ABPE pudele, 66,6 g -
V/DCP/20/0050-02 50 mg/ml 1 ABPE pudele, 40 g -
Enrox Max 100 mg/ml V/DCP/13/0032 KRKA, d.d., Novo mesto, Slovēnija QJ01MA90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Enrofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 30-Jul-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0032-01 100 mg/ml 1 Multiflakons, 100 ml [JPG] [JPG]
Flordofen 300 mg/ml V/DCP/13/0039 Dopharma Research B.V., Nīderlande QJ01BA90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Florfenicol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 09-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Nov-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0039-01 300 mg/ml 1 Polipropilēna flakons, 250 ml -
V/DCP/13/0039-02 300 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/13/0039-03 300 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/13/0039-04 300 mg/ml 1 Stikla flakons, 250 ml -
Rabigen Mono - V/NRP/93/0046 Virbac S.A., Francija QI07AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Rabies virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 22-Oct-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0046-01 10 Flakons, 1 deva -
V/NRP/93/0046-03 50 Flakons, 1 deva -

3081 record

© Food and veterinary service · 2026 Cookies policy